Latest News about RLMD
Recent news which mentions RLMD
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
December 04, 2024
From Benzinga
Relmada Therapeutics Stock Plummets Losing 80% Value - Here's Why
December 04, 2024
From Benzinga
Nasdaq Surges 150 Points; ISM Services PMI Falls In November
December 04, 2024
From Benzinga
Dow Gains 250 Points; Salesforce Shares Jump After Q3 Results
December 04, 2024
From Benzinga
RLMD Stock Earnings: Relmada Therapeutics Beats EPS for Q2 2024
August 07, 2024
Tickers
RLMD
From InvestorPlace
From Benzinga
7 Penny Biotech Stocks to Triple Your Investment
May 28, 2024
From InvestorPlace
Tickers
RLMD
From InvestorPlace
Tickers
RLMD
From InvestorPlace
Earnings Scheduled For March 19, 2024
March 19, 2024
From Benzinga
Relmada Therapeutics And 2 Other Penny Stocks Insiders Are Buying
February 01, 2024
From Benzinga
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
From Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
January 04, 2024
From Benzinga
From InvestorPlace
12 Health Care Stocks Moving In Thursday's Pre-Market Session
September 21, 2023
From Benzinga
FDA's Rejection of Sage/Biogen's Zuranolone Boosts Prospects for Axsome's Auvelity, Analyst Says
August 07, 2023
From Benzinga
From InvestorPlace
Earnings Scheduled For May 11, 2023
May 11, 2023
From Benzinga
Earnings Scheduled For March 23, 2023
March 23, 2023
From Benzinga
Vistagen Poised To Begin Phase 1 Trial Of A Fast-Acting Antidepressant Nasal Spray In First Quarter Of 2023
January 17, 2023
From Benzinga
Looking Into Relmada Therapeutics's Recent Short Interest
January 03, 2023
Tickers
RLMD
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.